Overview

Prophylaxis of Neuropathic Pain by mémantine

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate if memantine administered during 4 weeks beginning 2 weeks before surgery induces a decrease of painful intensity 3 months after surgery, compared to placebo group.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborator:
Dr Xavier DURANDO/Dr Marie-Ange MOURET/Dr Christine VILLATTE, Jean-Perrin Cancer Center, Clermont-Ferrand Hospital
Treatments:
Memantine